In humans, the dystonia-linked ATP5MC3N106K mutation causes a reduction in ATP production and oxygen consumption (Neilson et al., 2022), and MT-ATP6 mutations are linked to severe neurological conditions (Dautant et al., 2018; Galber et al., 2021). Here, MT-ATP6 is linked to Dystonia.